Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-10-08
K
Kyle R. Urquhart
Role not yet determined Is this you? Add your title
Also affiliated: University of Tennessee Health Science Center (2016); University of Arkansas Medical Center (2019)
4 h-index
11 pubs
76 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Kyle R. Urquhart's research focuses on the pharmacological characterization of drugs, particularly opioid analogs and their potential for abuse and dependence. He investigates the in vivo dependence liability of novel fentanyl analogues, contributing to scientific understanding that can inform drug policy. Urquhart also studies the effects of prenatal exposure to substances like norbuprenorphine, examining its impact on fetal opioid dependence and neonatal opioid withdrawal syndrome. His work includes the development and validation of translational animal models, such as a rat model for neonatal abstinence syndrome, to better understand and potentially treat these conditions. Urquhart's research also extends to the effects of environmental factors like ambient temperature and social housing on behavior and physiology following drug administration. He has authored 11 publications with 76 citations and an h-index of 4. Key collaborators include William E. Fantegrossi and Saki Fukuda, both at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 4
- Publications: 11
- Citations: 76
Selected Publications
-
In vitro and in vivo pharmacological characterization of fentanyl analogs (2025)
-
Between land and water: Hydraulic engineering in the Tlalixcoyan basin, Veracruz, Mexico (2021)
-
Effects of Ambient Temperature and Social Housing on Locomotor Activity, Thermoregulation, and Weight Loss Following “Binge” Administration of Structurally‐Related Abused Psychostimulants (2020)
-
In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome (2019)
-
2421 Development and validation of a translational rat model of neonatal abstinence syndrome (2018)
Collaboration Network
Top Collaborators
William E. Fantegrossi
University of Arkansas Medical Center
4 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- In vitro and in vivo pharmacological characterization of fentanyl analogs
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
- Effects of Ambient Temperature and Social Housing on Locomotor Activity, Thermoregulation, and Weight Loss Following “Binge” Administration of Structurally‐Related Abused Psychostimulants
Lauren Russell
University of Arkansas for Medical Sciences
3 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
- Effects of Ambient Temperature and Social Housing on Locomotor Activity, Thermoregulation, and Weight Loss Following “Binge” Administration of Structurally‐Related Abused Psychostimulants
Lisa K. Brents
University of Arkansas at Fayetteville
2 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Bryce A. Griffin
University of Arkansas at Fayetteville
2 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Caitlin Caperton
University of Arkansas at Fayetteville
2 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Christian V. Cabanlong
University of Arkansas at Fayetteville (US)
2 shared publications
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Catheryn D. Wilson
University of Arkansas at Fayetteville
2 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Amy Patton
University of Arkansas at Fayetteville (US)
2 shared publications
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Alexander W. Alund
University of Arkansas at Fayetteville
2 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
S. Michael Owens
University of Arkansas at Fayetteville
2 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Jeffery H. Moran
University of Arkansas at Fayetteville
2 shared publications
In database
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Brad Martins
University of Arkansas for Medical Sciences (US)
1 shared publication
- 2421 Development and validation of a translational rat model of neonatal abstinence syndrome
Bradford Martins
University of Arkansas at Fayetteville (US)
1 shared publication
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
Marcelle Dina Zita
University of Arkansas at Fayetteville (US)
1 shared publication
- In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
William S. Hyatt
University of Arkansas for Medical Sciences (US)
1 shared publication
- Effects of Ambient Temperature and Social Housing on Locomotor Activity, Thermoregulation, and Weight Loss Following “Binge” Administration of Structurally‐Related Abused Psychostimulants
Similar Researchers
Based on overlapping research topics
Brenda M. Gannon
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Disease Models, Animal
Michael D. Berquist
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Disease Models, Animal
Brian J. Parks
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Maternal and Perinatal Health Interventions
Lindsey Morrison
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Disease Models, Animal
Padma Kotapati
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Behavioral and Psychological Studies
Melinda G. Gunnell
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Disease Models, Animal